GLP-1 drugs can be pricey, with list prices topping $1,000 for a month’s supply, and 54% of people who have used the drugs told survey-takers that it was difficult to afford them, with 22% ...
(The Hill) — A new poll from the health policy nonprofit KFF found that one in eight adults say they’ve taken a GLP-1 agonist, the obesity and diabetes medications that include Ozempic ...
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...
About one in eight, or 12%, respondents in a recent survey said they had tried one of the new diabetes or weight loss drugs, with only about half of them (6%) still taking the costly medicines at ...
About 12% of American adults say they have used one of the increasingly popular weight loss and diabetes drugs known as GLP-1s, and 6% say they are currently taking such a drug, according to a new ...
(CNN) — About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million ...
May 10 (Reuters) – About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed ...